Učitavanje...
Cardiac Resynchronization—A Heart Failure Perspective
Over the past 15–20 years the development of new heart failure pharmacologic therapy has lowered mortality by 30–40% for this serious and prevalent clinical syndrome, within clinical trials conducted in patients with a dilated cardiomyopathy phenotype. However, over the past 5 years progress in the...
Spremljeno u:
| Izdano u: | Ann Noninvasive Electrocardiol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Blackwell Publishing, Inc.
2005
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6932049/ https://ncbi.nlm.nih.gov/pubmed/16274412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1542-474X.2005.00076.x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|